Global Blood Glucose Monitoring Systems Market Size By End User (Diagnostic Centers, Home Care, Clinics, Hospitals), By Application (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes), By Geographic Scope And Forecast

Blood Glucose Monitoring Systems Market Size And Forecast

Blood Glucose Monitoring Systems Market size was valued at USD 12.92 Billion in 2022 and is projected to reach USD 22.20 Billion by 2030, growing at a CAGR of 7% from 2023 to 2030.

One of the most recent technical advances in the area of diabetes care is continuous glucose monitoring (CGM). A CGM system is a type of glucose monitor that works by inserting a biosensor into the skin through a transcutaneous or subcutaneous path. The embedded sensor detects glucose levels in interstitial fluid or blood and sends the data to a receiver through a transmitter. Due to their many advantages over other glucose monitoring devices, these systems play an important role in diabetes management.

These devices, unlike traditional glucose monitors, allow for continuous monitoring of glucose levels, which is critical for preventing diabetic complications. Furthermore, GCMS technology has paved the way for the long-awaited closed-loop artificial/bionic pancreas. As a result, glucose monitoring system manufacturers are concentrating their efforts on the production of novel and technologically advanced GCMS. It can be used in a variety of age groups, healthcare environments (diagnostic centers/clinics, hospital ICUs, and home healthcare), and geographies. As a result, the demand for continuous glucose monitoring devices offers lucrative prospects for both GCMS and insulin pump manufacturers.

The demand is expected to be driven by the rising incidence of diabetes, as well as the growing geriatric population, which is vulnerable to diabetes. Increased understanding of diabetes preventive treatment and new product releases are also propelling the market forward. Diabetes is a medical disorder in which the pancreas is unable to produce insulin, resulting in an elevated glucose level in the body. BGM (blood glucose monitoring) systems are both cost-effective and essential for proper diagnosis and care. Blood sugar levels are measured with these instruments, which is an important step in diabetes care. It also aids in the prevention of other health problems including neuropathy, retinopathy, and cardiovascular disease.

Global Blood Glucose Monitoring Systems Market Definition

People use glucometers, or portable blood glucose meters, to monitor their blood sugar levels. These analyze a small volume of blood, typically from the tip of a finger. To extract blood, a lancet gently pricks the skin. Blood sugar meters show you how high or low your blood sugar is right now. The most important thing you can do to treat type 1 or type 2 diabetes is to check your blood sugar levels regularly. You will be able to see what changes the numbers, such as a change of diet, medicine, or exercise.

Blood Glucose Monitoring Systems are a vital part of routine diabetic treatment and are characterized as the process of measuring the diabetes level in the blood. It aids in the detection of blood glucose levels that are below the defined target range. Blood glucose monitoring systems assist in tracking patient progress as well as observing the impact of medications and treatments on blood glucose levels, providing valuable insight into diabetes management.

Many products known as blood glucose meters are available on the market to monitor blood sugar levels. Different forms of diabetes, such as type 1, type 2, and gestational diabetes, may benefit from these. Diabetes is becoming more common across the world, with 90 percent of patients suffering from type 2 diabetes mellitus. The two main types of blood glucose monitoring systems are self-monitoring blood glucose (SMBG) and continuous glucose monitoring (CGM).

Individual patterns of blood glucose fluctuations are revealed by blood glucose monitoring, which aids in the preparation of meals, tasks, and when to take medications. Furthermore, monitoring enables a rapid response to high blood sugar (hyperglycemia) or low blood sugar (hypoglycemia) (hypoglycemia). The hormones insulin and glucagon regulate the amount of glucose in the blood. The pancreas produces these hormones, which function on liver cells. The liver serves as a glucose ‘reservoir’ for the body.

Global Blood Glucose Monitoring Systems Market Overview

One of the major factors driving the global glucose monitoring system market is the rise in the number of diabetic patients. Diabetes is becoming more common as a result of an unhealthy lifestyle, a poor diet, excessive alcohol intake, and a lack of physical activity. In addition, as healthcare costs rise, so does spending on self-monitoring blood glucose levels.

The growing geriatric population and the high prevalence of people living with diabetes are thought to be the primary drivers of demand for glucose monitoring devices. The market for glucose monitoring devices is being fueled by the increasing adoption of continuous monitoring systems and improving technical advances in blood glucose monitoring devices.

furthermore, the global demand is accelerating as people become more aware of diabetes prevention strategies and new drugs are introduced. The adoption of cutting-edge healthcare technology and rising disposable income in urban areas are expected to drive consumer demand. The growing emphasis on developing creative techniques that benefit end-users is boosting market growth.

However, due to a manufacturing flaw or a mistake in the results, this industry has suffered specific losses. In addition, the market’s growth is hampered by the availability of Continuous Glucose Monitors (CGM). Inadequate reimbursement policies in developing countries, as well as the high cost of system maintenance, would limit the growth of the glucose monitoring devices market over the forecast period. For market participants, determining the accuracy of glucose meters is a major challenge. The glucose monitoring system market is also hampered by a scarcity of trained personnel in hospitals and clinics.

Many other factors, such as a large number of patients, increased population access to health facilities, increased awareness about point-of-care testing, and growing government healthcare spending in developing countries, all contribute to the global glucose monitoring system market’s development. The global glucose monitoring system market is expected to expand rapidly in the future due to the high potential in established economies’ used markets.

Global Blood Glucose Monitoring Systems Market Segmentation Analysis

The Global Blood Glucose Monitoring Systems Market is Segmented on the Basis of End User, Application, And Geography.

Blood Glucose Monitoring Systems Market, By End User

• Diagnostic Centers
• Home Care
• Clinics
• Hospitals

Based on the End User, the market is segmented into Diagnostic Centers, Home Care, Clinics, & Hospitals. The hospital segment held the largest revenue share of over 42.0% in 2022 and is anticipated to lead the market over the forecast period due to the improving infrastructure and increasing healthcare expenditure in hospitals. Moreover, the reliable data that BGM devices provide practitioners in a fraction of a second and the improvement in patients’ quality of life have increased their adoption in the outpatient as well as inpatient hospital settings. Hospitals have additional provisions to store and transfer patient information. Furthermore, during the COVID-19 pandemic, the FDA allowed the use of CGM devices in hospitals, and the possibility of another pandemic in the future is expected to enhance segment growth.

Blood Glucose Monitoring Systems Market, By Application

• Type 2 Diabetes
• Type 1 Diabetes
• Gestational Diabetes

Based on the Application, the market is segmented into Type 2 Diabetes, Type 1 Diabetes, & Gestational Diabetes. Blood glucose testing systems, which typically involve using a glucose meter and test strips, are used by both type 1 and type 2 diabetes patients to measure their blood glucose levels at home or in clinical settings. Regular monitoring helps individuals with diabetes make informed decisions about managing their condition, such as adjusting medication, dietary choices, and physical activity levels.

Blood Glucose Monitoring Systems Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on the Regional Analysis, the Global Blood Glucose Monitoring Systems Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Because of its well-established healthcare industry, North America led the market. Obesity’s prevalence, high medication costs, technical advances, and new product launches are all expected to propel the regional market forward. Due to a rise in the geriatric population, which is vulnerable to diabetes, Europe is projected to gain a large market share over the forecast period.

Furthermore, the region’s demand for BGM is being boosted by developments in its healthcare sector and the introduction of advanced medical products. In the forecast period, Asia Pacific is expected to be a lucrative regional market. The development of the regional market is aided by improvements in healthcare facilities and reimbursement policies in emerging economies. Due to its high diabetes population and rapid economic growth, China will lead the APAC region.

Key Players

The “Global Blood Glucose Monitoring Systems Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Bayer AG, Life scan, Inc., Dexcom, Inc., Sanofi, Elly Lilly and Company, Elbit Systems Ltd, B Braun Melsungen AG.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Blood Glucose Monitoring Systems market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in Global Blood Glucose Monitoring Systems Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our <